X-group (possible homology)

299 YbaK/ProRS associated domain

Open in classification tree →

Ligands and drugs

673

Member domains

with ligand contacts (≤ 4 Å)

3.0% of members

with DrugDomain annotations

1.9% of members

with a DrugBank compound

1.5% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

Proteins with classified ligands

Superclasses bound (of 23)

—

Superclasses per 20 proteins

fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

Superclass	Proteins	Expected	Ratio	Significance
Homogeneous non-metal compounds	2	0.9	2.36×	not tested
Nucleosides, nucleotides, and analogues	1	1.1	0.92×	not tested
Homogeneous metal compounds	1	1.9	0.52×	not tested

enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBank	PDB ligand	Name	Domains
DB02684	5CA	5'-O-(L-Cysteinylsulfamoyl)adenosine	1
DB03376	A5A	5'-O-(N-(Alanyl)sulfamoyl)adenosine	1

Most frequently bound compounds

PDB ligand	Name	Domains in contact
MGmetal	MAGNESIUM ION	4
CL	CHLORIDE ION	2
5CA	5'-O-(N-(L-CYSTEINYL)-SULFAMOYL)ADENOSINE	1
A5A	'5'-O-(N-(L-ALANYL)-SULFAMOYL)ADENOSINE	1
HGmetal	MERCURY (II) ION	1